Evidence map›Paper›PMID 24056030›Full record

ArticleFree radical biology & medicine2013

Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons.

Gloria A Benavides, Qiuli Liang, Matthew Dodson, Victor Darley-Usmar, Jianhua Zhang

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Rock inhibitors in Alzheimer's disease.Frontiers in aging · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Nuclear receptor binding factor 2 (NRBF2) is required for learning and memory.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gloria A BenavidesCenter for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Qiuli LiangCenter for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Matthew DodsonCenter for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Victor Darley-UsmarCenter for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Jianhua ZhangCenter for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA; Department of Veterans Affairs, Birmingham VA Medical Center, Birmingham, AL 35233, USA. Electronic address: zhanja@uab.edu.
University of Alabama at Birmingham · USBirmingham VA Medical Center · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
Alpha-synuclein degradation mechanismsR01NS064090 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHANG, JIANHUA · 2010 to 2014
$1.6M
NIDDK NIH HHS P30 DK079626NINDS NIH HHS NIHR01-NS064090NINDS NIH HHS R01 NS064090
6 · The paper itself

Abstract

Excessive nitric oxide (NO) production is known to damage mitochondrial proteins and the autophagy repair pathway and so can potentially contribute to neurotoxicity. Accordingly, we hypothesized that protection against protein damage from reactive oxygen and nitrogen species under conditions of low oxygen by the autophagy pathway in neurons would be impaired by NO and enhance bioenergetic dysfunction. Rat primary cortical neurons had the same basal cellular respiration in hypoxia as in normoxia, whereas NO-exposed cells exhibited a gradual decrease in mitochondrial respiration in hypoxia. Upon reoxygenation, the respiration in NO-treated cells did not recover to prehypoxic levels. Hypoxia-reoxygenation in the presence of NO was associated with inhibition of autophagy, and the inability to recover during reoxygenation was exacerbated by an inhibitor of autophagy, 3-methyladenine. The effects of hypoxia could be recapitulated by inhibiting glycolytic flux under normoxic conditions. Under both normoxic and hypoxic conditions NO exposure induced immediate stimulation of glycolysis, but prolonged NO exposure, associated with irreversible inhibition of mitochondrial respiration in hypoxia, inhibited glycolysis. Importantly, we found that NO inhibited basal respiration under normoxic conditions only when glucose was absent from the medium or glycolysis was inhibited by 2-deoxy-d-glucose, revealing a novel NO-dependent mechanism for the inhibition of mitochondrial respiration that is modulated by glycolysis. Taken together these data suggest an oxygen-dependent interaction between mitochondrial respiration, glycolysis, and autophagy in protecting neuronal cells exposed to NO. Importantly, they indicate that mitochondrial dysfunction is intimately linked to a failure of glycolytic flux induced by exposure to NO. In addition, these studies provide new insights into the understanding of how autophagy and NO may play interactive roles in neuroinflammation-induced cellular damage, which is pertinent to our understanding of the pathology of neurodegenerative diseases in which excessive NO is generated.

Indexed as

AdenineAnimalsAutophagyCell HypoxiaCells, CulturedCell SurvivalDeoxyglucoseEndothelial CellsEnergy MetabolismGlycolysisMitochondriaMitochondrial ProteinsNeuronsNitric OxideRatsRats, Sprague-Dawley3-methyladenineAdenineDeoxyglucoseMitochondrial ProteinsNitric OxideReactive Nitrogen SpeciesReactive Oxygen Species2-deoxyglucose2-DG3-MA3-methyladeninecarbonyl cyanide 4-(trifluoromethoxy)phenylhydrazonechloroquineCQDetaNONOateDetaNO, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolateECARextracellular acidification rateFCCPFree radicalsGlucoseLC3microtubule-associated protein light-chain 3Mitochondrianitric oxide synthaseNOSOCRoxygen consumption rate

Identifiers

PMID24056030
PMCPMC3859859
OpenAlexW1991724769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.